메뉴 건너뛰기




Volumn 94, Issue 2, 2013, Pages 214-217

The CLIPMERGE PGx program: Clinical implementation of personalized medicine through electronic health records and genomics-pharmacogenomics

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; DNA; SEROTONIN UPTAKE INHIBITOR; SIMVASTATIN; TRICYCLIC ANTIDEPRESSANT AGENT; WARFARIN;

EID: 84880716424     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2013.72     Document Type: Article
Times cited : (126)

References (5)
  • 1
    • 79952254324 scopus 로고    scopus 로고
    • US Food and Drug Administration Accessed February 2013
    • US Food and Drug Administration. Table of Pharmacogenomic Biomarkers in Drug Labels. http://www.fda.gov/drugs/scienceresearch/researchareas/ pharmacogenetics/ucm083378.htm (2013). Accessed February 2013.
    • (2013) Table of Pharmacogenomic Biomarkers in Drug Labels
  • 2
    • 82955233708 scopus 로고    scopus 로고
    • Personalizing medicine with clinical pharmacogenetics
    • Scott, S.A. Personalizing medicine with clinical pharmacogenetics. Genet. Med. 13, 987-995 (2011).
    • (2011) Genet. Med , vol.13 , pp. 987-995
    • Scott, S.A.1
  • 3
    • 79951803720 scopus 로고    scopus 로고
    • Pharmacogenomics: Noninferiority is sufficient for initial implementation
    • Altman, R.B. Pharmacogenomics: "noninferiority" is sufficient for initial implementation. Clin. Pharmacol. Ther. 89, 348-350 (2011).
    • (2011) Clin. Pharmacol. Ther , vol.89 , pp. 348-350
    • Altman, R.B.1
  • 5
    • 79951809825 scopus 로고    scopus 로고
    • CPIC: Clinical pharmacogenetics implementation consortium of the pharmacogenomics research network
    • Relling, M.V. & Klein, T.E. CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network. Clin. Pharmacol. Ther. 89, 464-467 (2011).
    • (2011) Clin. Pharmacol. Ther , vol.89 , pp. 464-467
    • Relling, M.V.1    Klein, T.E.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.